Phase 2 clinical trials of locally developed COVID-19 vaccines are nearly completed and doses are expected to be available by the end of July, President Tsai Ing-wen (蔡英文) said yesterday.
Tsai made the remarks after visiting the Central Epidemic Command Center (CECC) along with Premier Su Tseng-chang (蘇貞昌) in the morning as Taipei and New Taipei City entered the fourth day under level 3 COVID-19 prevention measures.
The vaccines being developed by Medigen Vaccine Biologics Corp (高端疫苗) and United Biomedical Inc (聯亞生技) are entering the final stage of phase 2 clinical trials, Tsai said, adding that the government would fully support the firms while checking the safety and quality of the jabs.
Photo: CNA
Taiwan has taken delivery of 117,000 vaccine doses purchased directly from AstraZeneca PLC and 199,200 doses of the same vaccine through the COVAX initiative.
A total of 220,352 doses had been administered as of yesterday, CECC data showed.
A surge in local COVID-19 infections over the past week has increased people’s willingness to be inoculated, as well as the pressure on the government to procure more doses.
GAVI, the Vaccine Alliance on Monday said that more AstraZeneca vaccines would be delivered to Taiwan soon.
GAVI, which is coleading the COVAX scheme set up last year to ensure fair access to vaccines among rich and poor nations, said it expects Taiwan to receive another delivery of AstraZeneca vaccines by the end of next month at the latest.
Representative to the US Hsiao Bi-khim (蕭美琴) yesterday wrote on Facebook that since the US started rolling out vaccines at the end of last year, the Ministry of Foreign Affairs and the Taipei Economic and Cultural Representative Office (TECRO) in the US have been urging Washington to help Taiwan obtain vaccines.
Hsiao’s remarks followed criticism that the government has been putting more effort into helping Latin American allies obtain vaccines than it did for Taiwan.
The US had an urgent need for vaccines at the time, so it did not respond to Taiwan’s request positively, Hsiao said, adding that the ministry and the TECRO still helped the government sign a contract with vaccine maker Moderna, which is expected to start supplying COVID-19 vaccines to Taiwan in the middle of this year.
After meeting Americans’ demand for vaccines, Washington began helping poorer countries that have been hit hard by the pandemic, and now that Taiwan is reporting more local infections, the US has understood the nation’s urgent need for more jabs, she added.
US President Joe Biden has said the US would share AstraZeneca vaccines with the rest of the world and TECRO has been asking Washington to include Taiwan among the recipients, Hsiao said.
Additional reporting by CNA
A magnitude 5.6 earthquake struck off the coast of Yilan County at 12:37pm today, with clear shaking felt across much of northern Taiwan. There were no immediate reports of damage. The epicenter of the quake was 16.9km east-southeast of Yilan County Hall offshore at a depth of 66.8km, Central Weather Administration (CWA) data showed. The maximum intensity registered at a 4 in Yilan County’s Nanao Township (南澳) on Taiwan’s seven-tier scale. Other parts of Yilan, as well as certain areas of Hualien County, Taipei, New Taipei City, Taoyuan, Hsinchu County, Taichung and Miaoli County, recorded intensities of 3. Residents of Yilan County and Taipei received
Taiwan has secured another breakthrough in fruit exports, with jujubes, dragon fruit and lychees approved for shipment to the EU, the Ministry of Agriculture said yesterday. The Animal and Plant Health Inspection Agency on Thursday received formal notification of the approval from the EU, the ministry said, adding that the decision was expected to expand Taiwanese fruit producers’ access to high-end European markets. Taiwan exported 126 tonnes of lychees last year, valued at US$1.48 million, with Japan accounting for 102 tonnes. Other export destinations included New Zealand, Hong Kong, the US and Australia, ministry data showed. Jujube exports totaled 103 tonnes, valued at
TRUST: The KMT said it respected the US’ timing and considerations, and hoped it would continue to honor its commitments to helping Taiwan bolster its defenses and deterrence US President Donald Trump is delaying a multibillion-dollar arms sale to Taiwan to ensure his visit to Beijing is successful, a New York Times report said. The weapons sales package has stalled in the US Department of State, the report said, citing US officials it did not identify. The White House has told agencies not to push forward ahead of Trump’s meeting with Chinese President Xi Jinping (習近平), it said. The two last month held a phone call to discuss trade and geopolitical flashpoints ahead of the summit. Xi raised the Taiwan issue and urged the US to handle arms sales to
BIG SPENDERS: Foreign investors bought the most Taiwan equities since 2005, signaling confidence that an AI boom would continue to benefit chipmakers Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) market capitalization swelled to US$2 trillion for the first time following a 4.25 percent rally in its American depositary receipts (ADR) overnight, putting the world’s biggest contract chipmaker sixth on the list of the world’s biggest companies by market capitalization, just behind Amazon.com Inc. The site CompaniesMarketcap.com ranked TSMC ahead of Saudi Aramco and Meta Platforms Inc. The Taiwanese company’s ADRs on Tuesday surged to US$385.75 on the New York Stock Exchange, as strong demand for artificial intelligence (AI) applications led to chip supply constraints and boost revenue growth to record-breaking levels. Each TSMC ADR represents
RSS